[Clinical experience in the treatment of nail mycoses with the new antibiotic Bay b5097 (clotrimazol)].
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000419:Albuminuria / Q000139:chemically induced; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000188:drug therapy*
D000935:Antifungal Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Klinische Erfahrungen bei der Behandlung von Nagelmykosen mit dem neuen Antimykotikum Bay b 5097 (Clotrimazol.